Asset Management Corp’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$1.88M Sell
46,167
-671
-1% -$29K 1.48% 14
2022
Q4
$2.4M Sell
46,838
-773
-2% -$37.1K 2.01% 12
2022
Q3
$2.08M Sell
47,611
-640
-1% -$31.1K 1.25% 18
2022
Q2
$2.53M Sell
48,251
-8,265
-15% -$421K 1.64% 11
2022
Q1
$2.93M Sell
56,516
-4,277
-7% -$222K 1.46% 11
2021
Q4
$3.59M Sell
60,793
-3,931
-6% -$195K 1.78% 9
2021
Q3
$2.78M Sell
64,724
-3,924
-6% -$174K 1.4% 11
2021
Q2
$2.69M Buy
68,648
+2,494
+4% +$97K 1.54% 14
2021
Q1
$2.4K Sell
66,154
-3,492
-5% -$124K 1.03% 17
2020
Q4
$2.56M Sell
69,646
-7,366
-10% -$270K 1.43% 15
2020
Q3
$2.68M Sell
77,012
-664
-0.9% -$23.3K 1.63% 10
2020
Q2
$2.41M Buy
77,676
+4,354
+6% +$148K 1.54% 10
2020
Q1
$2.27M Buy
73,322
+12,835
+21% +$437K 2.03% 9
2019
Q4
$2.25M Buy
+60,487
New +$2.15M 1.59% 9

Other funds holding PFE

Asset Management Corp's PFE Position: Q1 2023 in Review

Asset Management Corp reduced its Pfizer (PFE) stake by 1.4% in Q1 2023, selling an estimated $29K and leaving 46,167 shares worth $1.88M. The position accounts for 1.48% of the portfolio, ranked #14.

Asset Management Corp first reported a position in PFE in Q4 2019 and has held it in 14 quarters since. The position peaked at $3.59M in Q4 2021. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Asset Management Corp held 46,167 shares of Pfizer worth $1.88M as of Q1 2023.
  • Asset Management Corp sold 671 Pfizer shares in Q1 2023, an estimated $29K.
  • Pfizer made up 1.48% of Asset Management Corp's portfolio in Q1 2023, its #14 holding.
  • Asset Management Corp first reported a position in Pfizer in Q4 2019 and has held it in 14 quarters since.
  • Asset Management Corp's Pfizer position peaked at $3.59M in Q4 2021.
  • 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Asset Management Corp's 13F filing for Q1 2023, filed 14 Apr 2023.